Rasagiline is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Rasagiline Mesylate.
| Product ID | 0093-3060_0c7edeb7-f1a4-4fa0-afed-6e037f785ed4 |
| NDC | 0093-3060 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Rasagiline |
| Generic Name | Rasagiline |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-01-03 |
| Marketing Category | NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC |
| Application Number | NDA021641 |
| Labeler Name | Teva Pharmaceuticals USA, Inc. |
| Substance Name | RASAGILINE MESYLATE |
| Active Ingredient Strength | 1 mg/1 |
| Pharm Classes | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2017-01-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA AUTHORIZED GENERIC |
| Application Number | NDA021641 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-01-03 |
| Ingredient | Strength |
|---|---|
| RASAGILINE MESYLATE | .5 mg/1 |
| SPL SET ID: | e802c83c-e581-4a11-b83d-1df47120078d |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-3060 | Rasagiline | Rasagiline |
| 0093-3061 | Rasagiline | Rasagiline |
| 16714-770 | Rasagiline | Rasagiline |
| 16714-771 | Rasagiline | Rasagiline |
| 42291-779 | Rasagiline | Rasagiline |
| 42291-780 | Rasagiline | Rasagiline |
| 42571-220 | RASAGILINE | Rasagiline |
| 42571-221 | RASAGILINE | Rasagiline |
| 47781-683 | Rasagiline | Rasagiline |
| 47781-690 | Rasagiline | Rasagiline |
| 67877-259 | Rasagiline | Rasagiline |
| 67877-260 | Rasagiline | Rasagiline |